Abstract
The contemporary American food environment makes energy-dense, nutrient-poor foods and beverages the “default” option for most consumers. Economic interventions like taxes can shift the relative prices of unhealthy foods to nudge consumers towards healthier options. Beverages with added sugar are a good starting point for food taxation; they constitute over 10 percent of caloric intake nationwide and provide little or no nutritional value. Current levels of taxation on sugar-sweetened beverages (SSBs) are too low to affect consumer behavior, but the implementation of a penny-per-ounce excise tax could lead to substantial public health benefits. Current estimates predict that a tax that raised the cost of SSBs by 20 percent could lead to an average reduction of 3.8 pounds per year for adults, causing the prevalence of obesity to decline from 33 to 30 percent. SSB taxes would also generate considerable revenue for public health and obesity prevention programs. Although the beverage industry is fighting such taxes with massive lobbying and public relations campaigns, support for the policies is increasing, especially when revenue is earmarked for obesity prevention.
Keywords: Sugar-sweetened beverages, soda, obesity, taxation, prevention, retina, Sugar-sweetened, gratification, overweight, grassroots, calories, consumption, synergistic, environment, Beverages, implementation, energy
Current Pharmaceutical Design
Title: Taxation as Prevention and as a Treatment for Obesity: The Case of Sugar-Sweetened Beverages
Volume: 17 Issue: 12
Author(s): Nicole L. Novak and Kelly D. Brownell
Affiliation:
Keywords: Sugar-sweetened beverages, soda, obesity, taxation, prevention, retina, Sugar-sweetened, gratification, overweight, grassroots, calories, consumption, synergistic, environment, Beverages, implementation, energy
Abstract: The contemporary American food environment makes energy-dense, nutrient-poor foods and beverages the “default” option for most consumers. Economic interventions like taxes can shift the relative prices of unhealthy foods to nudge consumers towards healthier options. Beverages with added sugar are a good starting point for food taxation; they constitute over 10 percent of caloric intake nationwide and provide little or no nutritional value. Current levels of taxation on sugar-sweetened beverages (SSBs) are too low to affect consumer behavior, but the implementation of a penny-per-ounce excise tax could lead to substantial public health benefits. Current estimates predict that a tax that raised the cost of SSBs by 20 percent could lead to an average reduction of 3.8 pounds per year for adults, causing the prevalence of obesity to decline from 33 to 30 percent. SSB taxes would also generate considerable revenue for public health and obesity prevention programs. Although the beverage industry is fighting such taxes with massive lobbying and public relations campaigns, support for the policies is increasing, especially when revenue is earmarked for obesity prevention.
Export Options
About this article
Cite this article as:
L. Novak Nicole and D. Brownell Kelly, Taxation as Prevention and as a Treatment for Obesity: The Case of Sugar-Sweetened Beverages, Current Pharmaceutical Design 2011; 17 (12) . https://dx.doi.org/10.2174/138161211795656783
DOI https://dx.doi.org/10.2174/138161211795656783 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mevalonate Cascade and Neurodevelopmental and Neurodegenerative Diseases: Future Targets for Therapeutic Application
Current Molecular Pharmacology A Key Role for Connexin Hemichannels in Spreading Ischemic Brain Injury
Current Drug Targets A Review of Maternal and Fetal Growth Factors in Diabetic Pregnancy
Current Diabetes Reviews Endothelial Extracellular Vesicles Produced by Senescent Cells: Pathophysiological Role in the Cardiovascular Disease Associated with all Types of Diabetes Mellitus
Current Vascular Pharmacology Unfoldomics of Human Genetic Diseases: Illustrative Examples of Ordered and Intrinsically Disordered Members of the Human Diseasome
Protein & Peptide Letters Dyslipidemia and Cardiovascular Disease Prevention in South Asians: A Review and Discussion of Causes, Challenges and Management Strategies
Current Diabetes Reviews Synthetic Androgens as Designer Supplements
Current Neuropharmacology Gestational Diabetes and the Metabolic Syndrome: Can Obesity and Small, Dense Low Density Lipoproteins be Key Mediators of this Association?
Current Pharmaceutical Biotechnology Polycystic Ovary Syndrome in Adolescents
Current Women`s Health Reviews miRNAs in Insulin Resistance and Diabetes-Associated Pancreatic Cancer: The ‘Minute and Miracle’ Molecule Moving as a Monitor in the ‘Genomic Galaxy’
Current Drug Targets Alveolar Capillary Dysplasia: A Lethal Developmental Lung Malformation
Current Respiratory Medicine Reviews Risk Factors for Myocardial Infarction in Women and Men: A Review of the Current Literature
Current Pharmaceutical Design Fetal Determinants of Type 2 Diabetes
Current Drug Targets Gestational Diabetes Mellitus: A Review from 2004
Current Diabetes Reviews Stem/Progenitor Cells and Biodegradable Scaffolds in the Treatment of Retinal Degenerative Diseases
Current Stem Cell Research & Therapy Development of Pyrazole Compounds as Antidiabetic Agent: A Review
Letters in Drug Design & Discovery Nicotinamide Phosphoribosyltransferase (Nampt): A Link Between NAD Biology, Metabolism, and Diseases
Current Pharmaceutical Design Long-Term Psychosexual Development in Genetic Males Affected by Disorders of Sex Development (46,XY DSD) Reared Male or Female
Current Pediatric Reviews Nutritional Aspects Relating to the Developmental Origins of Health and Disease
Current Women`s Health Reviews Inhibition of Matrix Metalloproteinases (MMPs) as a Potential Strategy to Ameliorate Hypertension-Induced Cardiovascular Alterations
Current Drug Targets